Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma
Publication Date
2023
Content Type
Article
PubMed ID:
Citation
Journal of Neuro-Oncology (2023) 165(1):101-112
2023
Article
Journal of Neuro-Oncology (2023) 165(1):101-112